These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21795879)

  • 1. Multidrug-resistant bacterial colonization of combat-injured personnel at admission to medical centers after evacuation from Afghanistan and Iraq.
    Hospenthal DR; Crouch HK; English JF; Leach F; Pool J; Conger NG; Whitman TJ; Wortmann GW; Robertson JL; Murray CK
    J Trauma; 2011 Jul; 71(1 Suppl):S52-7. PubMed ID: 21795879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to infection control challenges in the deployed setting: Operations Iraqi and Enduring Freedom.
    Hospenthal DR; Crouch HK; English JF; Leach F; Pool J; Conger NG; Whitman TJ; Wortmann GW; Murray CK; Cordts PR; Gamble WB
    J Trauma; 2010 Jul; 69 Suppl 1():S94-101. PubMed ID: 20622627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq.
    Scott P; Deye G; Srinivasan A; Murray C; Moran K; Hulten E; Fishbain J; Craft D; Riddell S; Lindler L; Mancuso J; Milstrey E; Bautista CT; Patel J; Ewell A; Hamilton T; Gaddy C; Tenney M; Christopher G; Petersen K; Endy T; Petruccelli B
    Clin Infect Dis; 2007 Jun; 44(12):1577-84. PubMed ID: 17516401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain following battlefield injury and evacuation: a survey of 110 casualties from the wars in Iraq and Afghanistan.
    Buckenmaier CC; Rupprecht C; McKnight G; McMillan B; White RL; Gallagher RM; Polomano R
    Pain Med; 2009 Nov; 10(8):1487-96. PubMed ID: 19843233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A descriptive analysis of patients admitted to the intensive care unit of the 10th Combat Support Hospital deployed in Ibn Sina, Baghdad, Iraq, from October 19, 2005, to October 19, 2006.
    Lundy JB; Swift CB; McFarland CC; Mahoney P; Perkins RM; Holcomb JB
    J Intensive Care Med; 2010; 25(3):156-62. PubMed ID: 20097667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection control challenges in deployed US military treatment facilities.
    Hospenthal DR; Crouch HK
    J Trauma; 2009 Apr; 66(4 Suppl):S120-8. PubMed ID: 19359955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of multidrug-resistant gram-negative bacteria recovered from Afghan patients at a deployed US military hospital.
    Sutter DE; Bradshaw LU; Simkins LH; Summers AM; Atha M; Elwood RL; Robertson JL; Murray CK; Wortmann GW; Hospenthal DR
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):854-60. PubMed ID: 21828965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of point-of-injury combat antimicrobials.
    Murray CK; Hospenthal DR; Kotwal RS; Butler FK
    J Trauma; 2011 Aug; 71(2 Suppl 2):S307-13. PubMed ID: 21814097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of multidrug-resistant bacteria from combat personnel evacuated from Iraq and Afghanistan at a single military treatment facility.
    Murray CK; Yun HC; Griffith ME; Thompson B; Crouch HK; Monson LS; Aldous WK; Mende K; Hospenthal DR
    Mil Med; 2009 Jun; 174(6):598-604. PubMed ID: 19585772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-negative multidrug-resistant organism colonization in a US military healthcare facility in Iraq.
    Ake J; Scott P; Wortmann G; Huang XZ; Barber M; Wang Z; Nikolich M; Van Echo D; Weintrob A; Lesho E
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):545-52. PubMed ID: 21558766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical care at Landstuhl Regional Medical Center.
    Fang R; Pruitt VM; Dorlac GR; Silvey SV; Osborn EC; Allan PF; Flaherty SF; Perello MM; Wanek SM; Dorlac WC
    Crit Care Med; 2008 Jul; 36(7 Suppl):S383-7. PubMed ID: 18594267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
    Hernández JR; Pascual A; Cantón R; Martínez-Martínez L;
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):77-82. PubMed ID: 12586030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Drug-Resistant Gram-Negative Infections in Deployment-Related Trauma Patients.
    Campbell WR; Li P; Whitman TJ; Blyth DM; Schnaubelt ER; Mende K; Tribble DR
    Surg Infect (Larchmt); 2017 Apr; 18(3):357-367. PubMed ID: 29173084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
    Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
    Martínez JA; Aguilar J; Almela M; Marco F; Soriano A; López F; Balasso V; Pozo L; Mensa J
    J Antimicrob Chemother; 2006 Nov; 58(5):1082-5. PubMed ID: 16950822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients.
    Weintrob AC; Roediger MP; Barber M; Summers A; Fieberg AM; Dunn J; Seldon V; Leach F; Huang XZ; Nikolich MP; Wortmann GW
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):330-7. PubMed ID: 20175687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
    Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
    J Infect; 2005 Oct; 51(3):211-7. PubMed ID: 16230218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.